Ashley Gallagher

Jenna Anderson, CEO of KiHealth Inc, and Amanda Wiley, marketing manager of HealthSource Marketing, discuss the evolving role of pharmacies in at-home testing.

Stephanie Downing, MBA, discusses expanding pharmacy services, clinical workflow efficiency, and revenue growth, highlighting the shift from traditional pharmacy roles to providing expanded clinical services.

The drug shows a decrease in proteinuria and is well tolerated and safe, including for Black patients with chronic kidney disease.

Data from the HERCULES phase 3 trial were presented at the 2025 Annual Meeting for the American Academy of Neurology for non-relapsing secondary progressive multiple sclerosis.

Pharmacists are well positioned to screen for diversion, monitor for opioid use disorder, and educate patients on opioid-related risks.

There were no statistically significant differences between cognitive behavioral therapy and mindfulness-based therapy in reducing the dosage for chronic lower back pain.

Further studies are needed to further confirm the association between glucagon-like peptide 1 medication and reductions in dementia risk.

Conflicting study findings show various associations between asthma and COVID-19; further data are needed.

Technology, such as continuous glucose monitors, changes the way patients are treated, but more work needs to be done for racial, ethnic, and socioeconomic disparities.

Texas reports over 480 cases of measles and 2 measles-related deaths, with 1 including an unvaccinated pediatric patient.

Technological evolution promises to enhance patient care, reduce errors, and provide intelligent support that augments human expertise rather than replacing it.

Clinical pharmacists counsel patients during the intervention and make informed medication changes based on the data received from continuous glucose monitoring (CGM).

Pharmacists can also provide education across all pillars of health, including exercise, wellness, and dietary changes.

Pharmacists are transforming health care delivery by breaking down traditional barriers to medication access and patient care.

Experts discuss the evolving landscape of pharmacy through technological advancements, professional development, and advocacy.

Previous research shows herpes zoster is associated with a higher long-term risk of subjective cognitive decline, with increased risk for men who carried APOE ε4.

As over-the-counter birth control becomes increasingly available, pharmacists are uniquely positioned to bridge critical gaps in reproductive health care.

As of April 2, 2025, liraglutide remained in shortage, with the drug first entering the FDA database on July 18, 2023.

Traditional approaches have typically relied on oral medications, which can expose the entire body to potentially harmful adverse effects.

All 3 types of virtual diabetes self-management interventions lead to better results in hemoglobin A1c over a 6-month period.

Glucocorticoid use for severe community-acquired pneumonia has been controversial due to the safety profile of these drugs.

Pharmacists can help manage complications from long COVID-19, as no medications can treat it.

Patients with pulmonary arterial hypertension (PAH) received the maximum tolerated dose of background therapy with sotatercept or the placebo to the therapy.

The integration of CGM into pharmacy practice represents a significant opportunity for pharmacists to provide enhanced patient care.

The outpatient endoscopic procedure modifies duodenal dysfunction and restores metabolic health.

The approval expands the flexibility of storing the vaccine to protect against smallpox events or mpox outbreaks.

In an era of persistent medical misinformation, addressing vaccine hesitancy has become a critical challenge for health care professionals.

As information changed rapidly, pharmacists quickly adapted their strategies by leveraging social media for updates to patients.

Tom DePietro, PharmD, owner of DePietro's Pharmacy, highlights the deep community connections that enabled the pharmacy to respond effectively to the pandemic.

Kari Franson, PharmD, PhD, BCPP, senior associate dean for academic and student affairs and professor of clinical pharmacy at the University of Southern California, discusses the risk factors and considerations for cannabis use disorder.